Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Hualan Group
301027
5
Hangzhou SDIC Microelectronics Inc.
688130
US Stock MarketDetailed Quotes
RLMD Relmada Therapeutics
- 0.2760
- -0.0100-3.50%
Trading Apr 11 09:41 ET
9.16MMarket Cap-0.10P/E (TTM)
0.2764High0.2688Low46.14KVolume0.2774Open0.2860Pre Close12.59KTurnover0.15%Turnover RatioLossP/E (Static)33.19MShares4.729952wk High0.26P/B8.44MFloat Cap0.240452wk Low--Dividend TTM30.57MShs Float54.0000Historical High--Div YieldTTM2.66%Amplitude0.2404Historical Low0.2720Avg Price1Lot Size
Market Insights
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Relmada Therapeutics Stock Forum
Relmada Cuts Losses by 25%: Key Pipeline Programs Hit Critical Phase in 2025
Will this be another $Tenon Medical (TNON.US)$
will this be an after hours runner??
Groundbreaking Tourette Treatment Shows 69% QoL Improvement in Clinical Trial - Relmada's Latest Acquisition
Relmada Therapeutics Acquires Potential Therapy for Tourette Syndrome from Asarina Pharma AB
Thursday, 6th February at 7:30 am
Relmada purchases Sepranolone, a Phase 2b ready asset, for the treatment of Tourette syndrome (TS) and other compulsion-related conditions from Asarina Pharma AB
Phase 2a results signaled improvement in Tourette symptoms, quality of life and robust overall safety, supporting Sepranolone as a new potential first line treatment option fo...
No comment yet